Compare Stocks

Date Range: 

 BioqualCleveland BioLabsEloxx PharmaceuticalsProMIS NeurosciencesNanoViricides
SymbolOTCMKTS:BIOQNASDAQ:CBLINASDAQ:ELOXOTCMKTS:ARFXFNYSEAMERICAN:NNVC
Price Information
Current Price$91.00$5.49$1.89$0.15$3.63
52 Week RangeN/AN/ABuyN/AN/A
MarketRank™
Overall Score0.90.61.40.00.4
Analysis Score0.00.03.30.00.0
Community Score2.63.22.90.02.1
Dividend Score0.00.00.00.00.0
Ownership Score0.80.00.00.00.0
Earnings & Valuation Score1.30.00.60.00.0
Analyst Ratings
Consensus RecommendationN/AN/ABuyN/AN/A
Consensus Price TargetN/AN/A$6.50N/AN/A
% Upside from Price TargetN/AN/A243.92% upsideN/AN/A
Trade Information
Market Cap$76.61 million$84.93 million$76.01 million$43.37 million$38.76 million
Beta-0.330.612.570.930.67
Average Volume358320,99899,834296,1601,879,614
Sales & Book Value
Annual Revenue$46.36 million$1.11 millionN/AN/AN/A
Price / Sales1.7676.51N/AN/AN/A
Cashflow$4.59 per shareN/AN/AN/AN/A
Price / Cash19.81N/AN/AN/AN/A
Book Value$27.46 per share$0.09 per share$0.91 per shareN/A$2.04 per share
Price / Book3.3161.00N/AN/AN/A
Profitability
Net Income$4.23 million$-2,650,000.00$-50,870,000.00$-5,570,000.00$-13,450,000.00
EPSN/AN/A($1.34)N/AN/A
Trailing P/E Ratio17.370.00N/AN/A0.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins9.12%-382.26%N/AN/AN/A
Return on Equity (ROE)17.62%-123.97%-163.87%N/A-43.79%
Return on Assets (ROA)9.81%-86.26%-89.65%-436.74%-38.50%
Dividend
Annual Payout$1.10N/AN/AN/AN/A
Dividend Yield1.21%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.52%N/AN/A
Current RatioN/A6.66%3.23%0.20%11.80%
Quick RatioN/A6.66%3.23%0.20%11.80%
Ownership Information
Institutional Ownership PercentageN/A2.59%21.49%0.03%7.32%
Insider Ownership Percentage39.24%1.03%33.40%N/A5.60%
Miscellaneous
EmployeesN/A225N/A17
Shares Outstanding896,00015.47 million40.22 million305.95 million10.68 million
Next Earnings Date9/21/2021 (Estimated)5/21/2021 (Estimated)8/5/2021 (Estimated)5/12/2021 (Estimated)6/28/2021 (Estimated)
OptionableNot OptionableNot OptionableOptionableNot OptionableOptionable
SourceHeadline
Marburgvirus Infection Market: Facts, Figures and Analytical Insights, 2020 to 2027| Emergent BioSolutions Inc, NanoViricides Inc, Theravectys SA and Others - Clark County BlogMarburgvirus Infection Market: Facts, Figures and Analytical Insights, 2020 to 2027| Emergent BioSolutions Inc, NanoViricides Inc, Theravectys SA and Others - Clark County Blog
clarkcountyblog.com - May 6 at 2:36 AM
Global Ebola Treatment Market by Type (Vaccine (Under Trials), Drugs (Under Trials)), By Application (Hospitals, Ambulatory Surgery Centres, Specialized Clinics, Army Camps (Veteran Facilities) ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028 – Good News Gum - Good News GumGlobal Ebola Treatment Market by Type (Vaccine (Under Trials), Drugs (Under Trials)), By Application (Hospitals, Ambulatory Surgery Centres, Specialized Clinics, Army Camps (Veteran Facilities) ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028 – Good News Gum - Good News Gum
goodnewsgum.com - May 5 at 11:31 AM
Viral Conjunctivitis Drugs Market Study 2021-2027 By Current And Upcoming Trends, Opportunities, Size, Trends And Forecast | Adenovir Pharma, Allergan, NanoViricides - Good News GumViral Conjunctivitis Drugs Market Study 2021-2027 By Current And Upcoming Trends, Opportunities, Size, Trends And Forecast | Adenovir Pharma, Allergan, NanoViricides - Good News Gum
goodnewsgum.com - May 4 at 8:19 PM
Anti-Infective Treatment Market Size, Status, Global Outlook and Forecast 2020-2026 – The Shotcaller - The ShotcallerAnti-Infective Treatment Market Size, Status, Global Outlook and Forecast 2020-2026 – The Shotcaller - The Shotcaller
theshotcaller.net - May 4 at 9:06 AM
Viral Conjunctivitis Pipeline Drugs Market is Thriving Worldwide with Leading Players Adenovir Pharma AB, Allergan Plc, NanoViricides, Inc, Shire Plc, NovaBay Pharmaceuticals, Inc - Clark County BlogViral Conjunctivitis Pipeline Drugs Market is Thriving Worldwide with Leading Players Adenovir Pharma AB, Allergan Plc, NanoViricides, Inc, Shire Plc, NovaBay Pharmaceuticals, Inc - Clark County Blog
clarkcountyblog.com - May 3 at 7:19 PM
Ebola Treatment Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Hemispherx Biopharma, BioCryst Pharmaceuticals, etc. - Good News GumEbola Treatment Market 2021 Is Rapidly Increasing Worldwide in Near Future | Top Companies Analysis- Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Hemispherx Biopharma, BioCryst Pharmaceuticals, etc. - Good News Gum
goodnewsgum.com - May 3 at 2:19 PM
If You Had Bought Brixmor Property Group (NYSE:BRX) Stock A Year Ago, You Could Pocket A 106% Gain Today - NasdaqIf You Had Bought Brixmor Property Group (NYSE:BRX) Stock A Year Ago, You Could Pocket A 106% Gain Today - Nasdaq
nasdaq.com - April 28 at 12:59 PM
Were Not Very Worried About NanoViricides (NYSEMKT:NNVC) Cash Burn Rate - NasdaqWe're Not Very Worried About NanoViricides' (NYSEMKT:NNVC) Cash Burn Rate - Nasdaq
nasdaq.com - April 28 at 12:59 PM
Antiviral Therapeutics Markets, Technologies, & Competitive Landscape Report 2021-2030 Featuring profiles of 195 Companies with 179 Collaborations - Yahoo NewsAntiviral Therapeutics Markets, Technologies, & Competitive Landscape Report 2021-2030 Featuring profiles of 195 Companies with 179 Collaborations - Yahoo News
news.yahoo.com - April 27 at 6:03 PM
Nano Therapy Market Growth strategies and with Leading Key Players: Pfizer, Ablynx, Smith & Nephew, NANOVIRICIDES – Clark County Blog - Clark County BlogNano Therapy Market Growth strategies and with Leading Key Players: Pfizer, Ablynx, Smith & Nephew, NANOVIRICIDES – Clark County Blog - Clark County Blog
clarkcountyblog.com - April 26 at 2:57 PM
Viral Conjunctivitis Pipeline Drugs industry analysis base on regional trends 2021-25 – FLA News - FLA NewsViral Conjunctivitis Pipeline Drugs industry analysis base on regional trends 2021-25 – FLA News - FLA News
flanewsonline.com - April 24 at 12:40 PM
Global Antiviral Therapeutics Markets & Technologies Report 2021: Approaches, Vaccines, Human Coronaviruses, Nanotechnology, Delivery, Competitive Landscape, 2020-2030 - ResearchAndMarkets.com - Business WireGlobal Antiviral Therapeutics Markets & Technologies Report 2021: Approaches, Vaccines, Human Coronaviruses, Nanotechnology, Delivery, Competitive Landscape, 2020-2030 - ResearchAndMarkets.com - Business Wire
businesswire.com - April 21 at 2:49 PM
Drug Antiinfective Market Report , Competitive Analysis, Proposal Strategy, Top Addressable Targets, Key Requirements - Clark County BlogDrug Antiinfective Market Report , Competitive Analysis, Proposal Strategy, Top Addressable Targets, Key Requirements - Clark County Blog
clarkcountyblog.com - April 17 at 1:26 PM
Anti-Infective Drugs Market Outlook, Opportunity and Demand Analysis Forecast 2020 – 2025 – Los Hijos de la Malinche - Los Hijos de la MalincheAnti-Infective Drugs Market Outlook, Opportunity and Demand Analysis Forecast 2020 – 2025 – Los Hijos de la Malinche - Los Hijos de la Malinche
loshijosdelamalinche.com - April 15 at 5:48 PM
Anti-Infective Drugs Market 2021 Overview, Opportunities, In-Depth Analysis by 2027 : Roche Pharma AG, GlaxoSmithKline, Novabay Pharmaceuticals, Novartis AG, Theravance, Sanofi-Aventis, NanoViricides, Pfizer - Jumbo NewsAnti-Infective Drugs Market 2021 Overview, Opportunities, In-Depth Analysis by 2027 : Roche Pharma AG, GlaxoSmithKline, Novabay Pharmaceuticals, Novartis AG, Theravance, Sanofi-Aventis, NanoViricides, Pfizer - Jumbo News
jumbonews.co.uk - April 13 at 8:50 AM
Covid-19 Outbreak Global Ebola virus infection drug Forecast 2020-2027 By Regions, Type and Application with Sales and Revenue Analysis | – ROUGH Magazine - ROUGH MagazineCovid-19 Outbreak Global Ebola virus infection drug Forecast 2020-2027 By Regions, Type and Application with Sales and Revenue Analysis | – ROUGH Magazine - ROUGH Magazine
rough.asia - April 8 at 7:30 PM
Nanostructured Drug Market Major Players Revenue Analysis Nanoviricides Inc., Ablynx NV, Pfizer Inc., Nanother - openPRNanostructured Drug Market Major Players Revenue Analysis Nanoviricides Inc., Ablynx NV, Pfizer Inc., Nanother - openPR
openpr.com - March 30 at 5:17 AM
Is it Time to Dump NanoViricides Inc (NNVC) Stock After it Is Down 1.40% in a Week? - InvestorsObserverIs it Time to Dump NanoViricides Inc (NNVC) Stock After it Is Down 1.40% in a Week? - InvestorsObserver
investorsobserver.com - March 26 at 2:08 PM
Buy-the-Dip Candidates: Lordstown Motors, GE, Ulta Beauty - TheStreetBuy-the-Dip Candidates: Lordstown Motors, GE, Ulta Beauty - TheStreet
thestreet.com - March 15 at 9:30 AM
Nanostructured Drug Market Likely to Boost Future Growth by 2026 | Moderna, NanoViricides, Celgene – Breakout Live - Breakout LiveNanostructured Drug Market Likely to Boost Future Growth by 2026 | Moderna, NanoViricides, Celgene – Breakout Live - Breakout Live
breakout.live - March 13 at 3:40 PM
Indiana AG continues business advisory roles - Dubois County Herald - The HeraldIndiana AG continues business advisory roles - Dubois County Herald - The Herald
duboiscountyherald.com - March 12 at 7:37 PM
NanoViricides Says Its COVID-19 Drug Candidates Are Effective In Animal Studies In Support Of FDA Pre-IND Application - BenzingaNanoViricides Says Its COVID-19 Drug Candidates Are Effective In Animal Studies In Support Of FDA Pre-IND Application - Benzinga
benzinga.com - March 11 at 10:35 PM
Indiana attorney general continues business advisory roles - Chicago TribuneIndiana attorney general continues business advisory roles - Chicago Tribune
chicagotribune.com - March 11 at 5:34 PM
Indiana attorney general continues business advisory roles | Govt-and-politics | kenoshanews.com - Kenosha NewsIndiana attorney general continues business advisory roles | Govt-and-politics | kenoshanews.com - Kenosha News
kenoshanews.com - March 11 at 1:28 PM
Indiana Attorney General Rokita being paid tens of thousands of dollars for advisory roles - IndyStarIndiana Attorney General Rokita being paid tens of thousands of dollars for advisory roles - IndyStar
indystar.com - March 10 at 8:07 PM
DateCompanyBrokerageAction
11/9/2020Eloxx PharmaceuticalsHC WainwrightReiterated Rating
6/10/2020Eloxx PharmaceuticalsCitigroupDowngrade
5/12/2020Eloxx PharmaceuticalsCanaccord GenuityReiterated Rating
5/8/2020Eloxx PharmaceuticalsJanney Montgomery ScottLower Price Target
5/8/2020Eloxx PharmaceuticalsPiper SandlerLower Price Target
8/8/2019Eloxx PharmaceuticalsSunTrust BanksLower Price Target
(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.